For example, isoquinoline alkaloids from Coptidis rhizoma like berberine are generally recognized as activators of adenosine 5′-monophosphate- (AMP-) activated protein kinase (AMPK) but could also exert therapeutic effects on T2DM through inhibition of protein tyrosine phosphatase 1B (PTP1B) and peroxisome proliferator-activated receptor gamma (PPARγ) [12–14]. This evidence concerns the gene PTPN1 and type 2 diabetes mellitus.